FMP
RDHL

Financial Management Professionals’s Redhill Biopharma RDHL Stock Holding History

Financial Management Professionals’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9
Closed -$17 – 1044
2025
Q2 		$17 Sell
9
-38
-81% -$77 ﹤0.01% 1013
2025
Q1 		$125 Buy
+47
New +$219 ﹤0.01% 975

Other funds holding RDHL

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $3.28B AUM 23.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $328M AUM 19.81% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

Financial Management Professionals's RDHL Position: Q3 2025 in Review

Financial Management Professionals sold out of Redhill Biopharma (RDHL) in Q3 2025, closing a stake of 9 shares — an estimated $17 sold.

Financial Management Professionals first reported a position in RDHL in Q1 2025 and held it in 2 quarters. The position peaked at $125 in Q1 2025. 14 funds tracked by Wall St. Rank hold RDHL as of Q3 2025.

  • Financial Management Professionals reported no remaining Redhill Biopharma position as of Q3 2025 after selling out during the quarter.
  • Financial Management Professionals sold 9 Redhill Biopharma shares in Q3 2025, an estimated $17.
  • Financial Management Professionals first reported a position in Redhill Biopharma in Q1 2025 and held it in 2 quarters.
  • Financial Management Professionals's Redhill Biopharma position peaked at $125 in Q1 2025.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2025.

Based on Financial Management Professionals's 13F filing for Q3 2025, filed 15 Oct 2025.